KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Non-Current Deffered Revenue (2016 - 2021)

Biolife Solutions (BLFS) has disclosed Non-Current Deffered Revenue for 11 consecutive years, with $64000.0 as the latest value for Q1 2021.

  • Quarterly Non-Current Deffered Revenue changed N/A to $64000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $64000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $71000.0 for FY2020, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q1 2021 was $64000.0 at Biolife Solutions, down from $71000.0 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $720932.0 in Q1 2017, with the low at $64000.0 in Q1 2021.
  • Average Non-Current Deffered Revenue over 4 years is $428022.4, with a median of $422828.0 recorded in 2018.
  • The sharpest move saw Non-Current Deffered Revenue surged 5306.31% in 2017, then tumbled 41.19% in 2018.
  • Over 4 years, Non-Current Deffered Revenue stood at $492000.0 in 2017, then dropped by 29.07% to $349000.0 in 2018, then tumbled by 79.66% to $71000.0 in 2020, then fell by 9.86% to $64000.0 in 2021.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $64000.0, $71000.0, and $349000.0 for Q1 2021, Q4 2020, and Q4 2018 respectively.